Abstract:We have previously demonstrated that the R193H mutation of cardiac troponin I (cTnI) caused restrictive cardiomyopathy (RCM) and early death in transgenic mice (Du et al., 2006). RCM mutants are also characterized by increased myofilament Ca 2+ sensitivity and impaired cardiac relaxation (Gomes et al., 2005; Du et al., 2008). Restrictive cleavage of the N-terminal extension of cTnI has been shown to desensitize myofilament to Ca 2+ and enhance diastolic function in transgenic mice (Yu et al., 2001; Feng et al., 2008; McConnell et al., 2009). N-terminal truncated cTnI (cTnI-ND) also had the ability to correct the diastolic dysfunction and increase the lifespan of RCM mice expressing the cTnI R193H mutant in a wild type cTnI null background (Li et al, 2010). In the present study, we produced double transgenic mice (Double-TG) expressing different levels of mutant cTnI R193H and cTnI-ND to investigate the dose-dependent rescue effect of cTnI-ND and determine the mechanisms behind its protective role in young and aged RCM mice. In 2-month-old Double-TG mice, the rescue of these animals is secondary to the desensitization of their myofilament to Ca 2+ and the fixing of their cardiac relaxation impairment by cTnI-ND. The correction of the diastolic dysfunction by cTnI-ND occurs in a dose-dependent manner as evidenced by cell-based assays, measuring cardiac cell contractility of the various Double-TG mouse lines, and by echocardiography. In addition, in 8-10-month-old Double-TG mice, the rescue of RCM mice by cTnI-ND is characterized by both the restoration of their diastolic function and the amelioration of their systolic function, since both diastolic and systolic functions deteriorate in aged RCM mice. Thus, this study allows determining the efficiency of cTnI-ND in the treatment of RCM and evaluating how the dosage of RCM mutant proteins may influence the cardiac function. Also, consistent with the beneficial effect of cTnI-ND on the function of non-myopathic aging hearts (Biesiadescki et al., 2010), these data demonstrate the ability of cTnI-ND to rescue the RCM phenotype not only by correcting diastolic dysfunction in young RCM mice, but also by improving systolic function in aged RCM mice.

Establishment of two cardiac-specific human cardiac troponin C mutation transgenic mice and comparative analysis

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy

Dose-dependent Diastolic Dysfunction and Early Death in a Mouse Model with Cardiac Troponin Mutations.

Establishing a New Human Hypertrophic Cardiomyopathy-Specific Model Using Human Embryonic Stem Cells

Allele-specific Differences in Transcriptome, Mirnome, and Mitochondrial Function in Two Hypertrophic Cardiomyopathy Mouse Models

Abstract 14427: Differences in Molecular Phenotype in Mouse and Human Hypertrophic Cardiomyopathy Suggest Need for Precision Medicine Approach to Treatment Based on Human Studies

Establishment and Phenotype Analysis of Cardiac-specific Creg Gene Conditional Knockout Mice

Morphological Study of Heart Development in CMV43CT Transgenic Mice

Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations

Abnormal Splicing in the N-terminal Variable Region of Cardiac Troponin T Impairs Systolic Function of the Heart with Preserved Frank-Starling Compensation.

Dose-Dependent Arrhythmia and Cardiac Dysfunction in Restrictive Cardiomyopathy Mice Due to Troponin Mutations

Development of apical hypertrophic cardiomyopathy with age in a transgenic mouse model carrying the cardiac actin E99K mutation

The TTN p. Tyr4418Ter mutation causes cardiomyopathy in human and mice

Phenotype And Functional Analyses In A Transgenic Mouse Model Of Left Ventricular Noncompaction Caused By A Dtna Mutation

Analysis of the Function of Heart in the Heart-specific Dkk3 Transgenic Mice

Age-Related Cardiac Dysfunction In Transgenic Mice Carrying Actin E99k Mutation

Abstract 9065: Dose-Dependent Rescue Effects by a Desensitizing TnI Molecule in a RCM Mouse Model

Application Of Echocardiography On Transgenic Mice With Cardiomyopathies

Abstract 11841: Gene Therapy Improves Pathological Cardiac Remodeling in Human Hypertrophic Cardiomyopathy Gene Variant Knock-In Mice

Protective action of tetramethylpyrazine phosphate against dilated cardiomyopathy in cTnT R141W transgenic mice